Bulletin
Investor Alert

New York Markets After Hours

Apellis Pharmaceuticals Inc.

NAS: APLS

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 19, 2022, 4:36 p.m.

/zigman2/quotes/202103251/composite

$

44.48

Change

0.00 0.00%

Volume

Volume 31,727

Quotes are delayed by 20 min

/zigman2/quotes/202103251/composite

Today's close

$ 43.52

$ 44.48

Change

+0.96 +2.21%

Day low

Day high

$41.81

$45.15

Open

52 week low

52 week high

$27.50

$73.00

Open

Insider Actions for Apellis Pharmaceuticals Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
05/02/2022 Federico Grossi
CHIEF MEDICAL OFFICER
2,500   Disposition at $43.56 per share. 108,900
04/29/2022 Pascal Deschatelets
Chief Scientific Officer
4,000   Disposition at $44.43 per share. 177,720
04/29/2022 Pascal Deschatelets
Chief Scientific Officer
4,000   Derivative/Non-derivative trans. at $2.67 per share. 10,680
04/25/2022 David O. Watson
General Counsel
5,000   Disposition at $50 per share. 250,000
04/22/2022 Andrew Sinclair Dunlop
Director
20,000   Derivative/Non-derivative trans. at $14 per share. 280,000
04/21/2022 Pascal Deschatelets
Chief Scientific Officer
1,875   0
04/21/2022 David O. Watson
General Counsel
1,875   0
04/21/2022 Federico Grossi
CHIEF MEDICAL OFFICER
1,875   0
04/20/2022 Mark DeLong
Senior Vice President
7,000   Disposition at $52.53 per share. 367,710
04/20/2022 Mark DeLong
Senior Vice President
7,000   Derivative/Non-derivative trans. at $15.52 per share. 108,640
04/14/2022 Alec Machiels
Director
1,250   Disposition at $50.9 per share. 63,625
04/14/2022 Alec Machiels
Director
1,250   Derivative/Non-derivative trans. at $2.67 per share. 3,337
04/05/2022 Lukas Scheibler
CHIEF INNOVATION OFFICER
609   Disposition at $60.09 per share. 36,594
04/05/2022 Lukas Scheibler
CHIEF INNOVATION OFFICER
609   Derivative/Non-derivative trans. at $13.85 per share. 8,434
04/04/2022 Lukas Scheibler
CHIEF INNOVATION OFFICER
1,249   Disposition at $57.8 per share. 72,192
04/04/2022 Lukas Scheibler
CHIEF INNOVATION OFFICER
1,437   Disposition at $56.86 per share. 81,707
04/04/2022 Lukas Scheibler
CHIEF INNOVATION OFFICER
818   Disposition at $55.84 per share. 45,677
04/04/2022 Lukas Scheibler
CHIEF INNOVATION OFFICER
3,504   Derivative/Non-derivative trans. at $13.85 per share. 48,530
04/01/2022 Lukas Scheibler
CHIEF INNOVATION OFFICER
11,496   Disposition at $55.05 per share. 632,854
04/01/2022 Lukas Scheibler
CHIEF INNOVATION OFFICER
11,496   Derivative/Non-derivative trans. at $13.85 per share. 159,219

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
10 Purchases
17 Sales
60,209
43,066
Last 6 months
46 Purchases
57 Sales
540,573
105,311
Last 12 months
75 Purchases
82 Sales
928,725
186,606

Officers and Executives

Dr. Cedric Francois
President, Chief Executive Officer & Director
Mr. Timothy Eugene Sullivan
Chief Financial Officer & Treasurer
Ms. Nur Nicholson
Chief Technical Operations Officer
Dr. Pascal Deschatelets
Chief Scientific Officer
Dr. Federico Grossi
Chief Medical Officer
Dr. Lukas Scheibler
Chief Innovation Officer
Dr. Jeffrey Eisele
Chief Development Officer
Mr. Ahmad Sadr
Vice President-Technical Operations
Mr. Adam Townsend
Chief Commercial Officer
Mr. Thomas Lackner
Senior Vice President & Head-Europe
Mr. James G. Chopas
Chief Accounting Officer, VP & Controller
Ms. Karen Lewis
Chief People Officer
Mr. Vahe Ghahraman
Senior Director-Global Regulatory Operations
Mr. David O. Watson
VP-Corporate Development & General Counsel
Dr. Lok Chung Chan
Chairman
Mr. Paul R. Fonteyne
Independent Director
Mr. Alec Machiels
Independent Director
Mr. Andrew Sinclair Dunlop
Independent Director
Ms. Stephanie Monaghan O'Brien
Independent Director
Link to MarketWatch's Slice.